TGM2 and Cowden disease: Serological autoimmune markers such as the IgA anti-tissue transglutaminase (TTG) and IgA anti-endomysial (EMA) antibodies are highly sensitive and specific, and they are now used for routine CD screening to identify ‘silent’ and ‘atypical’ forms of CD.